CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-25 | SCHULER JACK W 10% owner | Purchase · Warrants (Right to buy) | +133,333 | 133,333 | ||
| 2022-08-01 | Sandford Nicole President and CEO | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +5,000 | 5,000 | ||
| 2022-07-05 | Phan Ryan Thinh CSO & COO | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +200,000 | 200,000 | ||
| 2022-07-01 | Sandford Nicole President and CEO | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +5,000 | 5,000 | ||
| 2022-06-23 | Sharma Ruby Director | Grant or award | +114,218 | 114,218 | ||
| 2022-06-23 | Auerbach Robert D Director | Grant or award | +54,825 | 54,825 | ||
| 2022-06-23 | Auerbach Robert D Director | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +83,799 | 83,799 | ||
| 2022-06-01 | Sandford Nicole President and CEO | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +5,000 | 5,000 | ||
| 2022-05-16 | Palmieri Valerie Barber Executive Chair | Purchase | +43,994 | $0.57 | $25K | 267,088 |
| 2022-05-16 | Sandford Nicole President and CEO | Purchase | +98,000 | $0.76 | $75K | 136,160 |
| 2022-05-02 | Sandford Nicole President and CEO | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +5,000 | 5,000 | ||
| 2022-04-01 | Sandford Nicole President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2022-03-31 | Fralick Celeste Rachelle Director | Grant or award | +99,671 | 99,671 | ||
| 2022-03-31 | Sandford Nicole President and CEO | Grant or award | +23,033 | 55,435 | ||
| 2022-03-31 | Sandford Nicole President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-31 | Beechey Robert Harry Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-03-31 | Jordan Veronica GH Director | Grant or award | +62,140 | 349,659 | ||
| 2022-03-31 | Jordan Veronica GH Director | Grant or award | +11,516 | 361,175 | ||
| 2022-03-31 | Jordan Veronica GH Director | Grant or award · Employee Stock Option (Right to Buy) | +93,977 | 93,977 | ||
| 2022-03-31 | LAFRANCE JAMES T Director | Grant or award | +72,937 | 496,129 |
Page 11 of 15 · 296 trades